HTTP 200 OK
Allow: GET, POST, HEAD, OPTIONS
Content-Type: application/json
Vary: Accept
{
"count": 1608389,
"next": "https://info.mzalendo.com/api/v0.1/hansard/entries/?format=api&page=154935",
"previous": "https://info.mzalendo.com/api/v0.1/hansard/entries/?format=api&page=154933",
"results": [
{
"id": 1567532,
"url": "https://info.mzalendo.com/api/v0.1/hansard/entries/1567532/?format=api",
"text_counter": 14,
"type": "heading",
"speaker_name": "",
"speaker_title": "",
"speaker": null,
"content": "COMMUNICATION FROM THE CHAIR"
},
{
"id": 1567533,
"url": "https://info.mzalendo.com/api/v0.1/hansard/entries/1567533/?format=api",
"text_counter": 15,
"type": "heading",
"speaker_name": "",
"speaker_title": "",
"speaker": null,
"content": "BREAKFAST MEETING ON FOURTH BASIS FOR ALLOCATING THE SHARE OF NATIONAL REVENUE AMONGST COUNTIES"
},
{
"id": 1567534,
"url": "https://info.mzalendo.com/api/v0.1/hansard/entries/1567534/?format=api",
"text_counter": 16,
"type": "speech",
"speaker_name": "Hon. Kingi",
"speaker_title": "The Speaker",
"speaker": null,
"content": " Hon. Senators, as you will recall, the Motion on the consideration of the report of the Standing Committee on Finance and Budget on the Fourth Basis for allocating the share of national revenue among counties was scheduled for consideration on Tuesday, 27th May, 2025. However, before the Motion was moved, several Senators rose on point of orders highlighting the need for more time to interrogate the contents of the report, to better understand the Committee's recommendations. Several Senators expressed concern that at a meeting convened by the Standing Committee on Finance and Budget on 22nd May, 2025, consultations on the matter were The electronic version of the Senate Hansard Report is for information purposesonly. A certified version of this Report can be obtained from the Director, Hansard and AudioServices, Senate."
},
{
"id": 1567535,
"url": "https://info.mzalendo.com/api/v0.1/hansard/entries/1567535/?format=api",
"text_counter": 17,
"type": "speech",
"speaker_name": "Hon. Kingi",
"speaker_title": "The Speaker",
"speaker": null,
"content": "not exhaustive. Consequently, it was agreed that the Motion be deferred and rescheduled for debate on Tuesday, 3rd June, 2025. Hon. Senators, in this respect, the Standing Committee on Finance and Budget has organized another breakfast meeting to apprise Senators on the contents of the report, facilitate consultations and consensus-building on the way forward regarding the Fourth Basis for allocating the share of national revenue amongst counties. The breakfast meeting is scheduled to be held in the Senate Chamber, main Parliament buildings on Tuesday, 3rd June, 2025 at 7.30 a.m. Next Order."
},
{
"id": 1567536,
"url": "https://info.mzalendo.com/api/v0.1/hansard/entries/1567536/?format=api",
"text_counter": 18,
"type": "heading",
"speaker_name": "",
"speaker_title": "",
"speaker": null,
"content": "PETITION"
},
{
"id": 1567537,
"url": "https://info.mzalendo.com/api/v0.1/hansard/entries/1567537/?format=api",
"text_counter": 19,
"type": "heading",
"speaker_name": "",
"speaker_title": "",
"speaker": null,
"content": "PROPAGATION AND COMMERCIALIZATION OF NEW GENERATION MUTHEA ANTIVENOM IN KENYA"
},
{
"id": 1567538,
"url": "https://info.mzalendo.com/api/v0.1/hansard/entries/1567538/?format=api",
"text_counter": 20,
"type": "speech",
"speaker_name": "Sen. Okiya Omtatah",
"speaker_title": "",
"speaker": null,
"content": "Mr. Speaker, Sir, pursuant to Standing Order No.232(1)(b), I hereby present a Petition to the Senate concerning the propagation and commercialization of new generation (Muthea) Antivenom in Kenya. As you are aware under Article 119(1) of the Constitution- “Every person has a right to petition Parliament to consider any matter within its authority, including to enact, amend or repeal any legislation.” The salient issues raised in the petition are as follows- THAT the petitioners are citizens of Kenya living in Machakos County. For the past five years, they have been developing a new generation antivenom derived from a chemically synthesized version of the traditional Muthea Antivenom. THAT the petitioner's innovation was inspired by a snake bite death of a neighbour at Machakos Level 5 Hospital and further motivated by the 2019 Ministry of Health Policy document on snake bites, which led them to formalize and register their Antivenom with the Pharmacy and Poisons Board (PPB). THAT although their snake bite treatment initiative is lawful and has demonstrated preclinical efficacy, the petitioner's efforts to further research, innovate and commercialize the Antivenom have faced persistent obstruction and sabotage from individuals within key public health institutions. THAT the Antivenom, which is based on a formulation that has been used effectively for over 100 years, with zero death outcomes in areas such as Machakos and Kwale, has not been recognized or supported under the Universal Health Coverage (UHC) framework. THAT the petitioners have experienced multiple forms of administrative abuse, including being unlawfully required to pay Kshs100,000 to obtain a nondisclosure agreement, having their intellectual property rights violated through unauthorized experiments and being denied formal partnership opportunities despite proven efficacy of their products. The electronic version of the Senate Hansard Report is for information purposesonly. A certified version of this Report can be obtained from the Director, Hansard and AudioServices, Senate."
},
{
"id": 1567539,
"url": "https://info.mzalendo.com/api/v0.1/hansard/entries/1567539/?format=api",
"text_counter": 21,
"type": "speech",
"speaker_name": "Sen. Okiya Omtatah",
"speaker_title": "",
"speaker": null,
"content": "THAT the petitioner's samples have been used without their consent and that they have been denied access to the Kenya Medical Research Institute (KEMRI) premises without due process. THAT the petitioners have made efforts to resolve these matters through the relevant institutions, but all efforts have been unsuccessful. THAT none of the issues raised in the petition are pending before any court of law or other legal body. Consequently, the petitioners pray that the Senate intervenes in the matter with a view to- (1) Recommending measures to protect the petitioners' rights to research, innovate and commercialize the traditional Antivenom; (2) Conducting an inquiry and making recommendations on allegations of criminal abuse of office, sabotage and potential patent theft by specific individuals within public research institutions; (3) Recommending measures to support initiatives that would enable Kenya to transition from being a net importer of animal plasma-based Antivenom to being a global exporter of reliable chemically synthesized alternatives; and, (4) Recommending the development and implementation of regulatory guidelines to ensure that indigenous African inventors and non-institutional innovators have equitable access to research and development facilities through institutionalized partnerships with publicly funded research institutions. Mr. Speaker, Sir, that is the end of the Petition. It is presented by myself. The page bearing the petitioners’ names was not printed, unfortunately."
},
{
"id": 1567540,
"url": "https://info.mzalendo.com/api/v0.1/hansard/entries/1567540/?format=api",
"text_counter": 22,
"type": "speech",
"speaker_name": "Hon. Kingi",
"speaker_title": "The Speaker",
"speaker": null,
"content": " What is your last page, Sen. Omtatah?"
},
{
"id": 1567541,
"url": "https://info.mzalendo.com/api/v0.1/hansard/entries/1567541/?format=api",
"text_counter": 23,
"type": "speech",
"speaker_name": "Sen. Okiya Omtatah",
"speaker_title": "",
"speaker": null,
"content": "Mr. Speaker, Sir, the petitioners are Mr. Patrick Musilu, Mr. Tom Babu and Mr. Alfred Dosso. It is presented by me, the Senator from Busia, Sen. Okiya Omtatah Okoiti."
}
]
}